Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.55 +0.25 (+0.75%)
As of: Sep 30, 2026 · 10:25 AM EDT

Agios Pharmaceuticals (AGIO) Operating Margin (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) posted Operating Margin of -247.07% for Q2 2026, up 773.05 percentage points from -1020.12% a year earlier and up 283.27 percentage points from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Operating Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Margin at Agios Pharmaceuticals was -466.78%, up 662.35 percentage points year-over-year; for FY2025, it came in at -873.87%, up 292.60 percentage points from FY2024.

  • Annual Operating Margin has increased for three consecutive years, with a three-year change of +1858.21 percentage points (FY2022 to FY2025).
  • In prior years, Agios Pharmaceuticals' Operating Margin was -1166.47% in FY2024 (+293.05 pp), -1459.52% in FY2023 (+1272.55 pp) and -2732.07% in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Operating Margin since Q4 2020.
  • On a year-over-year basis, Operating Margin has increased in each of the last five quarters, with an average year-over-year change of +364.85 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Operating Margin in the past five years was Q1 2023, with a gain of 10541.36 percentage points; the weakest was Q1 2025, with a drop of 97.63 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was -530.34% (Q1 2026), -608.89% (Q4 2025) and -907.37% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Agios Pharmaceuticals 1.99 Bn 1.99 Bn 41.75 Mn -247.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -247.07%
Mar 31, 2026 -530.34%
Dec 31, 2025 -608.89%
Sep 30, 2025 -907.37%
Jun 30, 2025 -1,020.12%
Mar 31, 2025 -1,221.97%
Dec 31, 2024 -1,165.30%
Sep 30, 2024 -1,146.93%
Jun 30, 2024 -1,228.29%
Mar 31, 2024 -1,124.34%
Dec 31, 2023 -1,496.23%
Sep 30, 2023 -1,363.66%
Jun 30, 2023 -1,396.01%
Mar 31, 2023 -1,615.49%
Dec 31, 2022 -2,300.97%
Sep 30, 2022 -2,590.73%
Jun 30, 2022 -1,749.19%
Mar 31, 2022 -12,156.85%
Dec 31, 2020 -209.86%
Sep 30, 2020 -231.34%
API Access

Agios Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=AGIO&period=max&api_key=YOUR_API_KEY